Clinical Trial Detail

NCT ID NCT01676714
Title Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, Davis
Indications

lung non-small cell carcinoma

colorectal cancer

Therapies

Dovitinib

Age Groups: adult

No variant requirements are available.